Patent
Disclosed are compositions and methods for mitigating a tolerance effect from ingestion of cannabis-based medicines in human subjects, for example, subjects having an increased risk of unresponsiveness to one or more therapeutic agents such as, for example, antidepressants and antianxiety drugs. In some methods, the human subjects have been previously treated with one or more therapeutic agents such as, for example, antidepressants and antianxiety drugs, and have developed at least partial tolerance to the one or more therapeutic agents.
1. A method of treating a human suffering from autism spectrum disorder consisting essentially of administering isolated tetrahydrocannabinol butter to said human in need thereof to effectively treat the autism spectrum disorder is said human in need thereof.